Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome

AIM OF THE STUDY: To evaluate the toxicity, clinical effectiveness and survival rate of transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin in patients with muscle invasive bladder cancer. MATERIAL...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nowak-Sadzikowska, Jadwiga, Jakubowicz, Jerzy, Skóra, Tomasz, Pudełek, Katarzyna
Formato: Artigo
Idioma:Inglês
Publicado: Termedia Publishing House 2013
Assuntos:
Original Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934068/
https://ncbi.nlm.nih.gov/pubmed/24596519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2013.35276
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares